The Bespoke Gene Therapy Consortium (BGTC) is a research initiative of the US Foundation for the National Institutes of Health. The consortium consists of the FDA, NIH, five non-profit organizations, and 10 pharmaceutical companies.
References
Wikipedia
Bespoke Gene Therapy Consortium
Tags
- 2021 establishments in the United States
- Consortia in the United States
- Food and Drug Administration
- Gene therapy
- Genetic engineering in the United States
- National Institutes of Health
- Research in the United States
- Technology consortia